Somewhere in the long human effort to read the body's future from its present, a small group of researchers at Duke and the University of Minnesota has found that a few tiny molecules drifting in the blood may hint at how many years an older person has ahead. The work, reported in Aging Cell, centers on piRNAs, fragments once known mainly for guiding development and immunity, and it suggests that their quieter levels can signal longer survival among adults aged 71 and older. It matters because growing old has always carried a fog of uncertainty about who will thrive and who will falter, and a
A Simple Blood Test May Reveal Who Is Likely to Live Longer, Duke-Led Study Finds
Six small molecules predicted two-year survival with accuracy as high as 86 percent
Mark
So what did they actually find?
Mimi
That six small RNA molecules, piRNAs, measured in blood could predict whether adults 71 and older would survive two more years, with accuracy up to 86 percent.
Mark
And that beat things like age and cholesterol?
Mimi
For short-term survival, yes. It outperformed age, cholesterol, physical activity and more than 180 other clinical measures. Lifestyle mattered more over longer horizons.
Luke
Worth being careful with that 86 percent. It's described as "as high as," so it's the best case, not a typical result. The source doesn't say how it performs across every subgroup.
Mark
But they did validate it?
Mimi
In a second, independent group of older adults, and survival was confirmed through national mortality records.
Luke
Right, though the first cohort was North Carolina-based, and we aren't told how diverse the validation group was. That matters for a clinical test.
Mark
Does this mean piRNAs cause longer life?
Mimi
Kraus says it suggests a direct role, partly because reducing them extended lifespan in simpler organisms.
Luke
"Suggests" is doing real work there. Prediction isn't causation, and nothing here shows that lowering piRNAs in people extends life. That's exactly what they plan to test next.
Mimi
Including whether GLP-1 therapies or lifestyle changes move the levels.
Der Puls
- A familiar uncertainty haunts medicine: no one can yet say reliably which aging adult is headed for serious decline.
- Researchers sifted through 187 clinical factors and 828 small RNAs across more than 1,200 blood samples, searching for a signal in the noise.
- Six piRNA molecules emerged as predictors of two-year survival, reaching accuracy as high as 86 percent and outperforming age and cholesterol.
- The finding held up in a second, independent group of older adults, lending the result credibility beyond its first test.
- Next, the team is probing whether lifestyle changes or GLP-1 medications can shift these molecules, aiming for a practical blood test.
Somewhere in the long human effort to read the body's future from its present, a small group of researchers at Duke and the University of Minnesota has found that a few tiny molecules drifting in the blood may hint at how many years an older person has ahead. The work, reported in Aging Cell, centers on piRNAs, fragments once known mainly for guiding development and immunity, and it suggests that their quieter levels can signal longer survival among adults aged 71 and older. It matters because growing old has always carried a fog of uncertainty about who will thrive and who will falter, and a simple blood draw that offers clearer sight could help physicians act before decline arrives.
A blood test that reads a handful of tiny molecules might one day tell doctors whether an older adult is likely to live at least two more years. Researchers at Duke Health, working with colleagues at the University of Minnesota, report the findings in the journal Aging Cell. The molecules are piRNAs, small RNAs previously studied for their roles in development, regeneration and immune function.
As people age, it grows harder to tell who is on track for healthy years and who faces serious decline. The team measured piRNA levels in blood from adults aged 71 and older, drawing on a large North Carolina cohort and confirming survival through national mortality records. Using causal artificial intelligence and machine learning across 187 clinical factors and 828 small RNAs, they narrowed the signal to six piRNAs that predicted two-year survival with accuracy as high as 86 percent. The result held in a second, independent group.
Duke professor Virginia Byers Kraus said the surprise was that such a strong predictor came from a simple blood test, outperforming age, cholesterol, physical activity and more than 180 other measures for short-term survival. Lower levels of certain piRNAs were linked to longer life, echoing earlier work in simpler organisms, which hints that these molecules may play a direct role in longevity. Higher amounts may signal that something in the body has gone off track.
The next steps are to test whether lifestyle changes or GLP-1 therapies can alter piRNA levels, and to compare blood with tissue to understand how the molecules work. Kraus calls piRNAs micromanagers in the body, and the goal is a practical test that improves health as people age.
Researchers at Duke Health, working with colleagues at the University of Minnesota, report that a blood test measuring a handful of tiny RNA molecules can predict whether an older adult will live at least two more years. The findings appeared in the journal Aging Cell.
The molecules are called piRNAs. They are small RNAs previously known for their roles in regulating development, regeneration and immune function. The team measured piRNA levels in blood samples from adults aged 71 and older, and found that lower levels of certain piRNAs were strongly associated with longer survival.
The problem the work addresses is a familiar one in medicine: as people age, it becomes harder to tell who is on track for healthy years ahead and who faces a higher risk of serious decline. The researchers say a minimally invasive blood test could identify short-term survival risk earlier and help guide interventions meant to promote healthy aging.
The scale of the analysis was large. Using causal artificial intelligence and machine-learning techniques, the scientists examined 187 clinical factors and 828 different small RNAs across more than 1,200 blood samples. Those samples came from a large North Carolina-based cohort established in an earlier Duke-led study, and survival outcomes were confirmed through national mortality records.
Statistical modeling narrowed the signal to a group of just six piRNAs. Together, they predicted two-year survival with accuracy as high as 86 percent. The researchers then checked the result in a second, independent group of older adults, and it held.
In a statement, Duke professor Virginia Byers Kraus, an author of the paper, said the combination of a few piRNAs was the strongest predictor of two-year survival the team examined, stronger than age, lifestyle habits or any other health measure. What surprised her most, she said, was that the signal came from a simple blood test. For short-term survival, piRNAs outperformed age, cholesterol levels, physical activity and more than 180 other clinical measures. Lifestyle factors grew more influential for longer-term survival, but piRNAs still offered insight into underlying biology.
The pattern also echoes earlier work in simpler organisms, where reducing these molecules has been linked to longer lifespans. According to Kraus, that suggests piRNAs may play a direct role in longevity rather than merely track it. "We know very little about piRNAs in the blood," she said, "but what we're seeing is that lower levels of certain specific ones is better." Higher amounts, she added, may signal that something in the body is off track.
The next steps are already defined. The team plans to test whether lifestyle changes, medications or newer drug classes such as GLP-1-based therapies can alter piRNA levels. They also want to compare levels in blood with those in body tissues to understand how the molecules work. Kraus described piRNAs as micromanagers in the body and said the goal is a practical blood test that ultimately improves health as people age.
Bemerkenswerte Zitate
The combination of just a few piRNAs was the strongest predictor of two-year survival in older adults, stronger than age, lifestyle habits, or any other health measures we examined.— Virginia Byers Kraus, Duke professor and paper author
Möchten Sie die ganze Geschichte?
Das Original lesen bei Newsweek ↗
Science & Space